
Peter Farmakis
MBA, Founder, Chairman & Chief Executive Officer
Peter Farmakis is CEO, 32 Biosciences, a Chicago-based company focused on gut microbial organ research. Peter is an accomplished executive with diversified leadership experiences in the life science industry, including biotech, molecular diagnostics, and medical devices. As the CEO of 32 Bio Sciences , Peter leads the organization’s long-term strategy development. Peter’s board experience includes Chairman of the Board for 32 Bio Sciences. Peter’s past Board of Director roles include VitaHEAT Medical, Three Squared, and Health Industry Supply Chain Institute.
Throughout his career, Peter has held multiple commercial leadership positions in General Management with large industry diversified life science organizations like Johnson & Johnson and Abbott Laboratories. Prior to joining 32 Bio Science, Peter served as CEO VitaHEAT Medical and led successful exits for early-stage start-up companies, OraPharma and Unimed Pharmaceuticals.
Peter completed the Post-MBA General Management Executive Development Program at Northwestern University’s Kellogg School of Management. Peter attained his M.B.A. in Marketing and Strategic Management from the University of Illinois at Chicago and his B.A. in Pre-Physical Therapy and Psychology from the University of Illinois at Chicago.